Startup Spotlight: The Pill Club’s tele-birth control

By William Smith
San Francisco, California-based healthcare startup The Pill Club offers online birth control prescription and delivery. Operating in all 50 states in t...

San Francisco, California-based healthcare startup The Pill Club offers online birth control prescription and delivery.

Operating in all 50 states in the US, as well as Washington DC, the company both prescribes and delivers birth control. The former function is achieved via an online questionnaire, while the latter is based around automatic refills with free shipping. Free with insurance, the firm also offers medication to the uninsured for a price.

A total of $61.7mn has been raised by the company across four funding rounds since its foundation in 2014. In 2019, the firm raised some $51mn in a Series B round led by VMG Partners.

In a press release at the time Nick Chang, founder and CEO of The Pill Club, said: “Dependable, seamless and discreet aren’t words typically associated with obtaining birth control and contraceptives.

SEE ALSO:

“When we launched in 2016, we realized that many new members didn’t have easy access to the prescriptions they needed. Our driving force has always been to put power back into the hands of women, and we’re thrilled to work with our investors as we continue enabling members to make important personal decisions through our easy-to-use service.”

As the COVID-19 pandemic continues, The Pill Club framed its work on telemedicine as a potential lifeline for women denied access to contraception during the pandemic, saying in a blog post: “At Pill Club, we serve hundreds of thousands of women across the country, regardless if their local clinic remains open or closed. Telemedicine doesn’t require women to see a doctor in-person to get a prescription and is a safe and trusted resource for women who have questions about their sexual health needs. That’s key to opening access to women’s reproductive health care and essential to ensuring women have a safety net to fall back on during the COVID-19 outbreak.”

Share

Featured Articles

McKinsey: Women More Likely to die of Heart Attack Than Men

McKinsey Health Institute's Lucy Pérez says cardiovascular disease top killer of women yet physicians don't know their heart attack symptoms are different

Novo Nordisk Buys $1bn Cardior in CardioVascular Move

As Novo Nordisk expands into heart medicines, we profile the Danish pharma giant who in 1923 was the first to make insulin commercially available

Shoddy Chinese Syringes Sees BD Ramp-up Production

Becton Dickinson – a major supplier of syringes – said it has upped manufacturing in its US facilities after FDA warning on China-made products

AI Tool 'Picks up Early-stage Breast Cancers Doctors Missed'

Technology & AI

AstraZeneca Buys $2bn Fusion in Next-gen Cancer Drugs Move

Medical Devices & Pharma

Eli Lilly and Amazon Pharmacy Partner on Drugs Delivery

Digital Healthcare